Country: Spain
Description:
Aptus Biotech is a biotechnological start-up SME founded in 2010, whose main goal is the development of new applications based on aptamer technology. We are interested in the implementation of aptamer-based tools in multiple sectors as health, biotechnology, agriculture-food industry and others. The most important objective of Aptus Biotech is the generation of value through the development of innovative diagnostic and therapeutic applications based on aptamers.
Contact person:
Main Task:
Our main goal in the project is to select aptamers against the receptor Tas1R3, a biomarker for Non-Small Cell Lung Cancer (NSCLC). APTUS is going to characterize the affinity and specificity of the selected aptamers against the target protein. Finally, Tas1R3-aptamers are going to decorate Sphingomyelin nanoemulsions to improve the interaction of the nanoparticles with metastatic cancer cells, for detection and specific treatment of occult micrometastases and improve cancer survival.
Logos:
Av. Monforte de Lemos, 3-5. Pabellón 11. Planta 0 28029 Madrid